Conferences - Results from #8460

24th Int'l Prostate Cancer Update: Abstract - Efficacy and safety of radium-223 dichloride (radium-223) in patients who did or did not receive prior docetaxel in the phase 3 ALSYMPCA trial February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Role of optical spectroscopy in the diagnosis of prostatic cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Intermittent androgen deprivation with the gonadotrophin−releasing hormone (GnRH) antagonist degarelix February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Real-world corticosteroid utilization in prostate cancer patients treated with two new oral agents February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Prostate cancer patients demonstrate adherence to medication while on abiraterone acetate (AA) therapy February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Unsuspected metastases found during screening for a trial of patients with non-metastatic castration resistant prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Cost considerations for new oral therapies for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Effect of a 22-marker genomic classifier assay on adjuvant radiation therapy recommendations in patients with high-risk prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Robotic prostatectomy and the ambulatory surgery center – A transition to outpatient care February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Hematologic Safety of radium-223 dichloride (radium-223) in castration-resistant prostate cancer patients with bone metastases from the phase 3 ALSYMPCA trial: Baseline prognostic factor subgroup analysis February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - PSA kinetics following robotic stereotactic body radiotherapy for localized prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Degarelix monotherapy vs. luteinizing hormone-releasing hormone agonists plus antiandrogen flare protection in the treatment of men with advanced prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Cell cycle progression-combined risk score stratifies prostate cancer risk and significantly modifies treatment decisions in prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Robot-assisted laparoscopic prostatectomy (RALP): Comparison of subjective assessment of nerve sparing quality and post-operative erectile function February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Survival outcomes among men with clinically localized prostate cancer treated with radical prostatectomy, brachytherapy, cryosurgical ablation and IMRT: A single surgeon experience February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Transperineal prostate biopsies without an episode of sepsis or prostatitis February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Patient reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer: The Georgetown University experience February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Targeting the DNA binding domain of the androgen receptor as a potential therapy for prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Single-institution comparative study on the outcomes of salvage cryotherapy versus prostatectomy for radio-resistant prostate cancer February 20, 2014

24th Int'l Prostate Cancer Update: Abstract - Finding occult prostatic cancer: The value of transperineal mapping biopsies and epigenetic assays February 20, 2014

Page 424 of 472

email news signup